Related references
Note: Only part of the references are listed.Physiological and pathological roles of protein kinase A in the heart
Yuening Liu et al.
CARDIOVASCULAR RESEARCH (2022)
Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts
Gaia Calamera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer
Patrizia Di Iorio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Selectivity mechanism of phosphodiesterase isoform inhibitor through in silico investigations
Junhao Huang et al.
JOURNAL OF MOLECULAR MODELING (2022)
Inhibition of Colon Cancer Cell Growth by Phosphodiesterase Inhibitors Is Independent of cGMP Signaling
Yali Hou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)
A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP/PKG/CREB pathway
Jia-yi You et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Genetic Alterations in Benign Adrenal Tumors
Georgia Pitsava et al.
BIOMEDICINES (2022)
Long Term Survivals in Aggressive Primary Brain Malignancies Treated With an Adjuvant Ketogenic Diet
Kenneth A. Schwartz et al.
FRONTIERS IN NUTRITION (2022)
Phosphodiesterase 11 A (PDE11A), a potential biomarker for glioblastoma
Hyunji Lee et al.
TOXICOLOGICAL RESEARCH (2022)
The Role of PDE11A4 in Social Isolation-Induced Changes in Intracellular Signaling and Neuroinflammation
Katy Pilarzyk et al.
FRONTIERS IN PHARMACOLOGY (2021)
Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer's disease
Wei Qin et al.
HUMAN MOLECULAR GENETICS (2021)
Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors
Emilia Modolo Pinto et al.
CANCERS (2020)
Phenotypic and genotypic features of a large kindred with a germline AIP variant
Jakob Dal et al.
CLINICAL ENDOCRINOLOGY (2020)
Loss of Function of Phosphodiesterase 11A4 Shows that Recent and Remote Long-Term Memories Can Be Uncoupled
Katy Pilarzyk et al.
CURRENT BIOLOGY (2019)
PDE11A negatively regulates lithium responsivity
G. Pathak et al.
MOLECULAR PSYCHIATRY (2017)
Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair
Eric P. Knott et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice
Shweta Hegde et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Radiation-induced brain injury: low-hanging fruit for neuroregeneration
Terry C. Burns et al.
NEUROSURGICAL FOCUS (2016)
Alterations of Phosphodiesterases in Adrenocortical Tumors
Fady Hannah-Shmouni et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
Rare inactivating PDE11A variants associated with testicular germ cell tumors
Anand Pathak et al.
ENDOCRINE-RELATED CANCER (2015)
Phosphodiesterase sequence variants may predispose to prostate cancer
Rodrigo B. de Alexandre et al.
ENDOCRINE-RELATED CANCER (2015)
Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Michy Kelly
CURRENT PHARMACEUTICAL DESIGN (2014)
Identification of novel genetic variants in phosphodiesterase 8B ( PDE8B ), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours
Anya Rothenbuhler et al.
CLINICAL ENDOCRINOLOGY (2012)
Activation of PDE10 and PDE11 Phosphodiesterases
Ronald Jaeger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Phosphodiesterase 11A (PDE11A) Gene Defects in Patients with ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH): Functional Variants May Contribute to Genetic Susceptibility of Bilateral Adrenal Tumors
Delphine Vezzosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo
Robin J. Kleiman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment
Isaac Levy et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer
Fabio Rueda Faucz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Frequent Phosphodiesterase 11A Gene (PDE11A) Defects in Patients with Carney Complex (CNC) Caused by PRKAR1A Mutations: PDE11A May Contribute to Adrenal and Testicular Tumors in CNC as a Modifier of the Phenotype
Rossella Libe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents
Christopher J. Schmidt
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Mutations and Polymorphisms in the Gene Encoding Regulatory Subunit Type 1-Alpha of Protein Kinase A (PRKAR1A): An Update
Anelia Horvath et al.
HUMAN MUTATION (2010)
Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes
Enrico Patrucco et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
Michele P. Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeting Cyclic Nucleotide Phosphodiesterase in the Heart: Therapeutic Implications
Clint L. Miller et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2010)
Phosphodiesterases link the aryl hydrocarbon receptor complex to cyclic nucleotide signaling
Simone Kobe de Oliveira et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Functional Phosphodiesterase 11A Mutations May Modify the Risk of Familial and Bilateral Testicular Germ Cell Tumors
Anelia Horvath et al.
CANCER RESEARCH (2009)
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients
E. Peverelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Clinical and Genetic Heterogeneity, Overlap with Other Tumor Syndromes, and Atypical Glucocorticoid Hormone Secretion in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Compared with Other Adrenocortical Tumors
Hui-Pin Hsiao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes
Jerome Bertherat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging
K. Domek-Lopacinska et al.
BRAIN RESEARCH (2008)
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
Rossella Libe et al.
CLINICAL CANCER RESEARCH (2008)
In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay
Elizabeth L. Greene et al.
HUMAN MUTATION (2008)
N-terminal domain of Phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization
James L. Weeks et al.
BIOCHEMISTRY (2007)
Overview of PDEs and their regulation
Kenji Omori et al.
CIRCULATION RESEARCH (2007)
Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors
D. Vezzosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity
Hengming Ke et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population
Anelia Horvath et al.
CANCER RESEARCH (2006)
Phosphodiesterase 11: a brief review of structure, expression and function
A. Makhlouf et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
Phosphodiesterases in the CNS: targets for drug development
Frank S. Menniti et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Compartmentalized phosphodiesterase-2 activity blunts β-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway
M Mongillo et al.
CIRCULATION RESEARCH (2006)
Improving memory: A role for phosphodiesterases
A. Blokland et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mammalian G proteins and their cell type specific functions
N Wettschureck et al.
PHYSIOLOGICAL REVIEWS (2005)
3′,5′-Cyclic nucleotide phosphodiesterase 11A:: localization in human tissues
K Loughney et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Expression of PDE11A in normal and malignant human tissues
MR D'Andrea et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology
C Wayman et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Tumor necrosis factor-α-dependent expression of phosphodiesterase 2:: role in endothelial hyperpermeability
J Seybold et al.
BLOOD (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5
TR Dunkem et al.
CELLULAR SIGNALLING (2005)
Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons
T Sasaki et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression
AT Bender et al.
CELLULAR SIGNALLING (2004)
Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
J Prickaerts et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Phototransduction: crystal clear
KD Ridge et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system
DH Maurice et al.
MOLECULAR PHARMACOLOGY (2003)
cGMP signalling: different ways to create a pathway
J Roelofs et al.
TRENDS IN GENETICS (2003)
Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene
C Rentero et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Clinical and molecular genetics of Carney complex
F Sandrini et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology:: Augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD
L Groussin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene
M Hayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Phosphodiesterase 5 inhibitors: Current status and potential applications
DP Rotella
NATURE REVIEWS DRUG DISCOVERY (2002)
Presence of cyclic nucleotide phosphodiesterases PDE1, existing as a stable complex with calmodulin, and PDE3A in human spermatozoa
L Lefièvre et al.
BIOLOGY OF REPRODUCTION (2002)
Distinguishing the ORFs from the ELFs: short bacterial genes and the annotation of genomes
H Ochman
TRENDS IN GENETICS (2002)
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
C Mehats et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants
M Fidock et al.
CELLULAR SIGNALLING (2002)
Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells
N Kanda et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A) - Comparison of rat and human PDE11A splicing variants
K Yuasa et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Expression and role of phosphodiesterase 6 in the chicken pineal gland
F Morin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3
NA Glavas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic AMP-specific phosphodiesterase PDE4A10
G Rena et al.
MOLECULAR PHARMACOLOGY (2001)
Human Ca2+/calmodulin-dependent phosphodiesterase PDE1A:: novel splice variants, their specific expression, genomic organization, and chromosomal localization
H Michibata et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Cloning and characterization of two splice variants of human phosphodiesterase 11A
JM Hetman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression
K Yuasa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex
LS Kirschner et al.
NATURE GENETICS (2000)
Share Paper
